OneSource Specialty Pharma gets four observations from USFDA for Bangalore facility

31 Mar 2025 Evaluate

The United States Food and Drug Administration (USFDA) has conducted a routine current Good Manufacturing Practices (cGMP) inspection at the Unit 2 Facility of OneSource Specialty Pharma located at Bangalore. The inspection has concluded with four observations.

OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.


Onesource Specialty Share Price

1669.00 -16.55 (-0.98%)
08-Dec-2025 11:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.40
Dr. Reddys Lab 1275.70
Cipla 1509.15
Zydus Lifesciences 932.65
Lupin 2086.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×